StockData

Alcon vs STAAR Surgical

ALC and STAA side by side, both in measuring, analyzing, and controlling instruments; photographic, medical and optical goods; watches and clocks. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How ALC and STAA compare

STAAR Surgical grew revenue faster over the last twelve months (42.4% versus 4.9% for Alcon).

Alcon keeps more of each dollar of sales as profit, with a net margin of 9.4% compared with 0.16% at STAAR Surgical.

STAAR Surgical scores higher on the StockData Score (8 against 7 for Alcon), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricALCSTAA
Size and price
Market cap–$1.3B
Share price$74.12$26.39
Change, 1 year−6.7%2.1%
Change, 5 years−10.1%−76.0%
Beta (5Y)0.821.48
Employees25K957
StockData Score
Total score78 (better)
Valuation score00
Growth score11
Performance score2 (better)1
Health score46 (better)
Dividend score00
Valuation
P/S–4.0×
P/B–3.5×
EV/EBITDA–1593×
P/FCF–74.1×
FCF yield–1.3%
Growth
Revenue growth (TTM)4.9%42.4% (better)
Revenue growth, 5Y average8.8% (better)7.9%
Net income growth (TTM)−3.7%–
EPS growth (TTM)−3.4%–
Profitability
Gross margin55.2%73.6% (better)
Operating margin13.1% (better)0.21%
Net margin9.4% (better)0.16%
FCF margin16.6% (better)5.4%
Return on equity4.5% (better)0.15%
Return on invested capital4.6% (better)0.21%
Financial health
Debt / equity0.22 (better)0.00
Net debt / EBITDA2.47–
Interest coverage6.7×–
Current ratio2.094.68 (better)
Altman Z-score–8.28
Piotroski F-score6 (better)2
Dividends and buybacks
Payout ratio16.9%–
Shareholder yield–0.00%
Ownership
Held by institutions–110%
Held by insiders0.00%–
Insider net buying, 12 months–$21.7M
Short interest, % of float3.8%–

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.